Loading...

GlaxoSmithKline settles fraud case for $3 billion

| British drug-maker GlaxoSmithKline settled a federal fraud case by agreeing to pay $3 billion in fines, and pleading guilty to criminal charges over how it sold medications. Bob Orr reports.